Abstract:Eight platinum(II) complexes with the new chiral ligands, (1R,2R)-N-1-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine (R) or (1S,2S)-N-1-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine (S) as the carrier groups were designed, synthesized, and spectrally characterized. All platinum(II) complexes showed much better aqueous solubility than cisplatin and oxaliplatin. In vitro cytotoxicity of the compounds against human HepG-2, MCF-7, A549, and HCT-116 cell lines was evaluated. Results indicate that all compounds with R as the carrier group showed cytotoxicity against HCT-116, A549, and MCF-7 cell lines; however, all compounds with S as carrier group exhibited disappointing cytotoxicity against tested cell lines. Compound R2, bearing ClCH2COO- as leaving group, exhibited better cytotoxicity than that of carboplatin against A549 and MCF-7 cell lines and also showed close activity to oxaliplatin against HCT-116 cell line.

Synthesis and in Vitro Cytotoxicity of Platinum(Ii) Complexes with Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivatives As the Carrier Groups